SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.150+2.7%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: crysball who wrote (38)6/2/1997 11:39:00 AM
From: Bubba   of 668
 
CBMI will be featured at a few seminars this month which might explain the run-up. The science is great and the company is doing the right things by aligning themselves with Stryker and Biogen but this is a biotech stock and maybe 10% of them ever become shooting stars. I have traded the stock for over two years and experience tells me you sell on good news, above $11 and buy under $7. Not too exciting for such a promising company. If it gets away from me over $13, well, I made a little money. It may take a few more years before this company is real. I am tired of waiting(which could mean I will sell and never see my entry prices again).

With small caps in the tank, why would there be any long term, sustained interest in biotechs at this time? Investors are looking for stocks that could double or triple in the next quarter, hardly willing to hold stocks for 2-3 years that might have a chance for FDA approval. What is wrong with this market?

Sorry I sound so discouraged, any of you have anything to say that I am missing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext